Garefalakis Georgios Internist Oncologist
Consultant, 2nd Medical Oncology DepartmentEducation & Academic Qualifications
- Fellowship in Clinical and Translational Research in Breast Cancer, Jules Bordet Institute. Brussels, Belgium (2022)
- Specialty in Medical Oncology, Agios Savvas General Oncology Hospital. Athens, Greece (2021)
- Master of Science (MSc) in «Neoplastic Disease in Human: Diagnosis, modern therapy and research», National and Kapodistrian University of Athens (NKUA) (2020)
- Lung Clinical Observation Program for lung cancer, University Hospital of Leuven. Leuven, Belgium (11/2019)
- Diploma of the Hellenic Boards of Oncology Hellenic Society of Medical Oncology, Hellenic Academy of Oncology. Athens, Greece (2018)
- Medical License,Medical School Comenius University, Bratislava, Slovakia (2012)
Professional Experience
· Medical Oncologist YGEIA & MITERA Hospital (2021-Today)
· Fellowship in Clinical and Translational Research in Breast Cancer, Jules Bordet Institute. Brussels, Belgium (2022)
· Resident Doctor in Medical Oncology, 2nd Department of Medical Oncology, Agios Savvas General Oncology Hospital. Athens, Greece (2018-2021)
· Resident Doctor in Internal Medicine – Hematology, Hematology section of the 1st Department of Internal Medicine, Laiko General Hospital. Athens, Greece (2016-2017)
· Resident Doctor in Internal Medicine, 2nd Department of Internal Medicine, Elpis General Hospital. Athens, Greece (2014-2017)
· Compulsory military service as Sergeant Doctor in 2nd Department of Internal Medicine, 251 Air Force General Hospital. Athens, Greece (2012-2013)
Εducation Experience
· Tutor in HEAL Academy by HHG (Healthcare Education Advanced Learning). 2023
· Tutor in the Post Graduate program in Clinical Pharmacology of the Pharmacology School – University of Athens. Subject: Pathophysiology and treatment of ovarian and cervical cancer. 2022
· Tutor in the Hellenic Boards of Oncology. 2022
Clinical and Research Interest
•Breast Cancer
•Gynaecological Cancer
•Lung Cancer
•Gastrointestinal Cancer
Awards
Scholarship granted by the Hellenic Society of Medical Oncology (HeSMO) for fellowship in Clinical and Translational Research in Breast Cancer, Jules Bordet Institute. Brussels, Belgium (2022)
Bibliography
·Revision and translation of European Cancer Patient Guides in Greek (ESMO-European School of Medical Oncology):
1.Cervical Cancer: A. Assi, G. Garefalakis, J. Ntanasis-Stathopoulos, A. Tsiara, O. Fiste
2.Glioma: A. Agorastos, E. Aravantinou, E. Voulgaris, G. Garefalakis, A.Isaakidou,M. Liontos, Ch. Mikropoulos, P. Baxevanos, I. Binas, M. Nikolaou, K. Tsapakidis, K. Tsigaridas, N. Tsoukalas, O. Fiste and E. Fountzila
·Author of Manual for New Drugs in Oncology. 2nd Department of Medical Oncology, Agios Savvas General Oncology Hospital of Athens.
Recent Publications
•Isolated skeletal muscle recurrence of an originally nodal diffuse large B cell lymphoma: A case report and review of literature. Medicine (Baltimore). Spetsieris N, Giannakopoulou N, Variami E, Zervakis K, Rougala N, Garefalakis G, Skarlatou V, Viniou NA, Diamantopoulos P. 2018 Jan;97(3):e9608
•A case report of a very late response to 5-azacytidine in a patient with lower risk myelodysplastic syndrome: Time to update treatment guidelines for lower risk patients. Medicine (Baltimore). Spetsieris N, Diamantopoulos P, Zervakis K, Giannakopoulou N, Rougala N, Garefalakis G, Skarlatou V, Viniou NA. 2018 Apr;97(17):e0505
•Prognostic role white blood cell levels in patients with advanced pancreatic adenocarcinoma undergoing first-line chemotherapy. A.Ioannou, S Demiri, G Papaxoinis, V Rapti, E Klouva, E Sarris, P Baxevanos, G Garefalakis, G Goumas, P Gouveris, P Kourakos, G Koumakis. Annals of Oncology, Volume 30, Issue Supplement_4, July 2019
•A RARE CASE OF A PATIENT WITH SYNCHRONUS DIAGNOSIS OF BREAST AND RENAL CANCER. Ioannou A., Gouveris P., Garefalakis G., Baxevanos P., Papaxoinis G., Grivas A., Tryfonopoulos D., Koumakis G. FCO Supplementary issue 10(1)/2019
•Prognostic role of inflammatory biomarkers in patients with advanced pancreatic adenocarcinoma undergoing first-line chemotherapy. Α.Ioannou, S.Demiri, G.Papaxoinis, E.Sarris, E.Klouva, P.Baxevanos, G.Garefalakis, N.Pitsilos, A.Kyriakidou, I.Mavrogenis, G.Goumas, P.Gouveris, P.Kourakos, D.Tryfonopoulos, G.Koumakis. Annals of Oncology, Volume 31, Issue Supplement_4 July 2020